Opinion · 19 Dec 2025
Conference abstractPublished 13 Aug 2012
Flavocoxid, a natural approach to the management of osteoarthritis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
H umans have used botanical products as therapies for thousands of years. Only recently have active molecules have been identified, purified and their biochemical and physiological mechanisms determined. As a general rule, botanically derived compounds tend to have more benign side effects than synthetically designed drugs with similar therapeutic intent. For example, natural anti-inflammatory agents may not have the same side effect profile as non-steroidal anti-inflammatory drugs (NSAIDs) due to their broad and differing mechanisms of action. Flavocoxid (Limbrel�), a proprietary combination of baicalin and catechin purified from Scutellaria baicalensis and Acacia catechu, respectively, is indicated for the clinical dietary management of osteoarthritis (OA) under physician supervision as a medical food in the US. Rather than inhibiting the cyclooxygenase site of the COX enzymes as do NSAIDs, flavocoxid modulates the peroxidase moieties of COX-1 and COX-2, inhibits 5-lipoxygenase (5- LOX), and acts as an antioxidant both directly and by modulation of inducible inflammation through nuclear factor- Ã?º B (NF Ã?º B). Flavocoxid exhibits no major drug interactions, does not inhibit thromboxane production or affect platelet function, shows equivalent efficacy with statistically better gastrointestinal and renal safety compared to naproxen in head-to-head clinical trials and, in post-marketing surveillance, has not been reported to produce gastrointestinal bleeding, cardiovascular or renal toxicity. These broad mechanisms of action for flavocoxid appear to be additive providing a safer approach in the management of OA. Naturally occurring, less biochemically specifically targeted compounds should be considered as first-line therapeutics before the administration of more toxic NSAIDs for OA and other inflammatory conditions.
Subjects
RheumatologyOrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Rheumatology: Current Research.
Opinion · 19 Dec 2025
Specialized Care for Complex Rheumatic Disorders
Perspective · 19 Dec 2025
Rheumatology and Musculoskeletal Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalRheumatology: Current Research
- SubjectRheumatology
- SubjectOrthopaedics
- BylineArticles whose byline prints “Bruce P. Burnett”
